Acquiring Company
Medicus Pharma
Acquired Company
Antev
West Conshohocken
United KingdomBiotechnologyHealthcareTherapeuticsBiotechnologyHealth CareDescription
Medicus Pharma has completed its acquisition of the UK-based company Antev. This acquisition includes the clinical development program for Teverelix, a next-generation hormone antagonist. The program aims to address critical areas in men's health, including advanced prostate cancer. Medicus Pharma is now optimizing the study protocols to enhance efficiency and reduce costs.
Who to call at Medicus Pharma, and when
When Medicus Pharma changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Medicus Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Medicus Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Medicus Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Medicus Pharma makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Antev?
Antev was acquired by Medicus Pharma, based in West Conshohocken. The deal was reported on July 18, 2026. Medicus Pharma Ltd. (NASDAQ:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets. Medicus Pharma is publicly traded (MDCX) and operates in Biotechnology.
When did Medicus Pharma acquire Antev?
Medicus Pharma's acquisition of Antev was reported on July 18, 2026. Medicus Pharma has completed its acquisition of the UK-based company Antev. This acquisition includes the clinical development program for Teverelix, a next-generation hormone antagonist. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Antev do?
Antev is a clinical development company dedicated to advancing therapy programs for critical health conditions. It specializes in hormone therapies and innovative treatment options for urological health. It is privately held, operating in Biotechnology, and is based in United Kingdom.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.